Papillomavirus in the genesis of oral leukoplakia

Arkhiv Patologii

Volumn 76, Issue 1, 2014, Pages 32-36

  Babichenko, I I ^a   Rabinovich, O F ^b   Ivina, A A ^a   Rabinovich, I M ^b   Togonidze, A A ^b  

^a PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Human papillomavirus 76 type; Immunohistochemistry; Ki 67; Leukoplakia; Oral mucosa; P16^{INK4a< sup>}

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; VIRUS ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; FEMALE; GENETICS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKOPLAKIA; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; PAPILLOMA VIRUS; PATHOGENICITY; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ADULT; AGED; ANTIGENS, VIRAL; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KI-67 ANTIGEN; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE;

EID: 84899915415     PISSN: 00041955     EISSN: 23091266     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Feller L., Lemmer J. Field cancerization and oral leukoplakia. In: Dakubo G.D., ed. Field cancerization: basic science and clinical applications. Ontario, Canada: Nova Science; 2011:95-111.
2. Sciubba J.J. Oral cancer: the importance of early diagnosis and treatment. Am. J. Clin. Dermatol. 2001; 2 (4): 239-51.
3. Brandwein-Gensler M.S. Lesions of the oral cavity. In: Diagnostic surgical pathology of the head and neck. Philadelphia: Saunders/ Elsevier; 2009:191-308.
4. Neville B., Damm D., Allen C, Bouquot J. Oral and maxillofacial pathology. St. Louis: Saunders/Elsevier; 2009.
5. Dietrich T., Reichart P.A., Scheifele C. Clinical risk factors of oral leukoplakia in a representive sample of the US population. Oral Oncology. 2004; 40 (2): 158-63.
6. Acay R, Retende N., Fontes A., Aburad A., Nunes E, Sousa S. Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification. Oral Microbiol. Immunol. 2008; 23 (4): 271-4.
7. Parkin D.M., Bray F Chapter 2: the burden of HP-related cancers. Vaccine. 2006; 24 (Suppl. 3): 11-25.
8. Murphy N., Heffron C.C., King B., Ganuguapati U.G., Ring M., McGuiunness E. p16INKA positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem. Virchows Arch. 2004; 445 (6): 610-5.
9. Zhang H.S., Postigo A.A., Dean D.C. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16 INKa, TGF-beta and contact inhibition. Cell. 1999; 97 (1): 53-61.
10. Keating J. T., Cviko A., Riethdorf S., Riethdorf L., Quade B.J., Sun D. et al. Ki-67, cyclin E and p16INKA are complementary surrogate biomarkers for human papilloma virus - related cervical neoplasia. Am. J. Surg. Pathol. 2001; 25 (7): 884-91.
11. Klaes R., Friedrich T., Spitkovsky D., Ridder R., Rudy W., Retry U. et al. Overexpression of p16(INKA) as a specific marker for dys-plastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer. 2001; 92 (2): 276-84.
12. Klaes R., Benner A., Friedrich T., Ridder R., Herrington S., Jenkins D. et al. P16INKA immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am. J. Surg. Pathol. 2002; 26 (11): 1389-99.
13. Murphy N., Ring M., Killalea A.G., Uhlmann V., O'Donovan M., Mulcahy F. et al. p16INKa as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep Smears. J. Clin. Pathol. 2003; 56 (1): 56-63.
14. Hennessey P. T., Westra W.H., Califano J.A. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J. Dent. Res. 2009; 88 (4): 300-6.
15. Ha P.K., Califano J.A. The role of human papillomavirus in oral carcinogenesis. Clin. Rev. Oral Biol. Med. 2004; 15 (4): 188-96.
16. Feller L., Lemmer J. Oral leukoplakia as it relates to HPV infection: a review. Int. J. Dent. 2012:2012:540561. doi: 10.1155/2012/540561